281 related articles for article (PubMed ID: 20091248)
1. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis.
Haseen F; Murray LJ; Cardwell CR; O'Sullivan JM; Cantwell MM
J Cancer Surviv; 2010 Jun; 4(2):128-39. PubMed ID: 20091248
[TBL] [Abstract][Full Text] [Related]
2. Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?
Umlauff L; Weber M; Freitag N; Fairman CM; Heidenreich A; Bloch W; Schumann M
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):149-158. PubMed ID: 34193946
[TBL] [Abstract][Full Text] [Related]
3. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
Elife; 2024 Apr; 13():. PubMed ID: 38656229
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of BMI in relation to ADT use among early stage prostate cancer survivors.
Beehler GP; Wade M; Kim B; Steinbrenner L; Wray LO
J Cancer Surviv; 2009 Dec; 3(4):233-40. PubMed ID: 19760149
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
Yang U; Harikrishna A; Preda V; Chen J
Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
[TBL] [Abstract][Full Text] [Related]
6. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
7. Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study.
Levy ME; Perera S; van Londen GJ; Nelson JB; Clay CA; Greenspan SL
Urology; 2008 Apr; 71(4):735-9. PubMed ID: 18279933
[TBL] [Abstract][Full Text] [Related]
8. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
[TBL] [Abstract][Full Text] [Related]
9. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
[TBL] [Abstract][Full Text] [Related]
10. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
[TBL] [Abstract][Full Text] [Related]
11. Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study.
van Londen GJ; Levy ME; Perera S; Nelson JB; Greenspan SL
Crit Rev Oncol Hematol; 2008 Nov; 68(2):172-7. PubMed ID: 18706829
[TBL] [Abstract][Full Text] [Related]
12. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
[TBL] [Abstract][Full Text] [Related]
13. Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer.
Cheung AS; Hoermann R; Dupuis P; Joon DL; Zajac JD; Grossmann M
Eur J Endocrinol; 2016 Sep; 175(3):229-37. PubMed ID: 27340081
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis.
Botrel TE; Clark O; Lima Pompeo AC; Horta Bretas FF; Sadi MV; Ferreira U; Borges Dos Reis R
PLoS One; 2016; 11(6):e0157660. PubMed ID: 27308831
[TBL] [Abstract][Full Text] [Related]
15. The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis.
Shao W; Zhang H; Qi H; Zhang Y
PLoS One; 2022; 17(2):e0263918. PubMed ID: 35167609
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
Haseen F; Murray LJ; O'Neill RF; O'Sullivan JM; Cantwell MM
Trials; 2010 Aug; 11():86. PubMed ID: 20704726
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.
O'Neill RF; Haseen F; Murray LJ; O'Sullivan JM; Cantwell MM
J Cancer Surviv; 2015 Sep; 9(3):431-40. PubMed ID: 25916660
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
Owen PJ; Daly RM; Livingston PM; Fraser SF
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]